Results 191 to 200 of about 166,859 (297)

Recent progress on the development of hydrogel‐based microneedles for transdermal drug delivery

VIEW, EarlyView.
This study provides a comprehensive and up‐to‐date analysis of recent progress in HMN technology, covering fundamental transdermal delivery mechanisms and design principles, biomaterials used in HMN fabrication, drug loading and release strategies, and emerging therapeutic applications.
Mohammad Muhtasim Ittisaf, Salman Farsi Taharat, Md. Sadek Miah, Hasan Tasnim Salehin, M. Azam Ali, Shoeb Ahmed   +5 more
wiley   +1 more source

Exploring the Role of Skin Microbiota in Autoimmune Skin Diseases from a Bidirectional Mendelian Randomization Perspective. [PDF]

Clin Cosmet Investig Dermatol
Wang J, Wang X, Tao X, Yang Q, Zhang M, Wang Y, Liu S.   +6 more
europepmc   +1 more source

Psoriasis Triggers and Disease Activity: Analysis of Survey Data from the PSODEEP1 Study. [PDF]

Acta Derm Venereol
Duvetorp A, Reek JVD, Wikström J, Petersen MB, Zheng W, Lysell J, Skov L, Valenzuela F, Dyring-Andersen B, Eidsmo L.   +9 more
europepmc   +1 more source

Psoriasis [PDF]

BMJ, 2007
openaire   +2 more sources

Two Entities, One Patient

JEADV Clinical Practice, EarlyView.
Wael Zaina, Tomer Cohen, Judit Krausz, Michael Ziv, Roni P. Dodiuk‐Gad   +4 more
wiley   +1 more source

Guselkumab Safety in Patients With Latent Tuberculosis: Analysis of 11 Studies in Psoriatic Disease

The Journal of Dermatology, EarlyView.
ABSTRACT Certain psoriatic disease treatments, including tumor necrosis factor‐α inhibitors (TNFi), increase tuberculosis (TB) risk. Testing for latent TB infection (LTBI) before initiating systemic therapy has been standard practice for psoriasis (PsO) patients; however, updated consensus states routine testing is not required before initiating ...
Luis Puig, Tsen‐Fang Tsai, Enrique R. Soriano, Tina Bhutani, Megan Miller, Alexa P. Kollmeier, Shu Li, Hewei Li, Sarah Ofori, Jeffrey Pawlikowski, Elizabeth Adamson, Melinda Gooderham, Angela Londoño Garcia, Mark Lebwohl, Peter Nash   +14 more
wiley   +1 more source

Hidradenitis suppurativa and psoriasis: shared immunological links with metabolic-associated steatotic liver disease. [PDF]

Front Immunol
Chng WQ, Liew JJ, Liew CF, Muthiah M, Zheng MH, Oon HH.   +5 more
europepmc   +1 more source

Skin Metabolic Signatures of Psoriasis and Psoriasis Concurrent with Metabolic Syndrome

Liang Yan,1,2 Wenqiu Wang,1 Meihan Dong,1 Rui Wang,1 Chengxin Li1,3 1Department of Dermatology, The First Medical Center of Chinese PLA General Hospital, Beijing, 100853, People’s Republic of China; 2Department of Dermatology, General Hospital of Central
Yan L, Li C, Wang R, Dong M, Wang W
core  

A Serum N‐Glycan Ratio Associated With Disease Severity and Treatment Response in Psoriasis

The Journal of Dermatology, EarlyView.
ABSTRACT Psoriasis is a chronic, immune‐mediated inflammatory disease with heterogeneous manifestations. Reliable biomarkers reflecting disease severity and treatment response remain limited. Glycans—carbohydrate structures attached to proteins and lipids—play key roles in biological processes, contributing to functional specificity.
Kentarou Nishimura, Noritaka Oyama, Takumi Hasegawa, Hiroshi Kasamatsu, Takenao Chino, Takahiro Tokunaga, Kiyoshi Higashi, Koichi Saito, Keita Yamada, Minoru Hasegawa   +9 more
wiley   +1 more source

Curcumin alleviates depression-aggravated psoriasis by targeting MMP9-regulated apoptotic pathways. [PDF]

iScience
Lu J, Zhou C, Ma Y, Zhang N, Diao Z, Chen D, Tian X, Yin Z.   +7 more
europepmc   +1 more source